These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21127470)

  • 1. Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis.
    Gross O; Girgert R; Rubel D; Temme J; Theissen S; Müller GA
    Am J Hypertens; 2011 Mar; 24(3):355-61. PubMed ID: 21127470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition.
    Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS
    Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
    Elrashidy RA; Asker ME; Mohamed HE
    J Pharm Pharmacol; 2012 Jun; 64(6):862-71. PubMed ID: 22571265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
    Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
    J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin inhibitors--new direction in the treatment of arterial hypertension].
    Vasiuk IuA; Sadulaeva IA; Iushchuk EN; Trofimenko OS; Chirkov MV; Fedoseeva VS; Kulikov KG
    Ter Arkh; 2010; 82(9):53-9. PubMed ID: 21086622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D
    Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Pimenta E; Oparil S
    Cardiol Clin; 2008 Nov; 26(4):527-35. PubMed ID: 18929229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren combined with losartan in diabetes and nephropathy.
    Anderson S; Komers R
    N Engl J Med; 2008 Sep; 359(10):1069; author reply 1069-70. PubMed ID: 18777613
    [No Abstract]   [Full Text] [Related]  

  • 17. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M; Simioni N; Masiero A
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aliskiren combined with losartan in diabetes and nephropathy.
    Lindner T
    N Engl J Med; 2008 Sep; 359(10):1068-9; author reply 1069-70. PubMed ID: 18777612
    [No Abstract]   [Full Text] [Related]  

  • 19. Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling.
    Martins-Oliveira A; Castro MM; Oliveira DM; Rizzi E; Ceron CS; Guimaraes D; Reis RI; Costa-Neto CM; Casarini DE; Ribeiro AA; Gerlach RF; Tanus-Santos JE
    Int J Cardiol; 2013 Aug; 167(4):1199-205. PubMed ID: 22483258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of body weight and gender on the pharmacokinetics, pharmacodynamics, and antihypertensive efficacy of aliskiren.
    Jarugula V; Yeh CM; Howard D; Bush C; Keefe DL; Dole WP
    J Clin Pharmacol; 2010 Dec; 50(12):1358-66. PubMed ID: 20150520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.